Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.31 – $9.36
3% from low
Exchange
OTC Link
CS
Borrow rate
5.35%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M | $0 | $0 | $285.0K | $1.4M | $1.6M | $1.5M | $398.0K |
| Cost of revenue | $0 | $0 | $12.5M | $29.7M | $0 | $0 | $0 | $0 |
| Gross profit | $1.2M | $0 | −$12.5M | −$29.4M | $1.4M | $1.6M | $1.5M | $398.0K |
| Gross margin | 100.0% | — | — | -10318.9% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $5.0M | $12.0M | $12.5M | $29.7M | $38.8M | $48.0M | $43.8M | $18.4M |
| Operating income | −$7.3M | −$16.5M | −$22.2M | −$43.6M | −$56.3M | −$67.1M | −$96.3M | −$31.0M |
| EBITDA | −$7.2M | −$16.5M | −$22.1M | −$42.6M | −$53.9M | −$65.3M | −$60.3M | −$29.1M |
| Net income | −$6.0M | −$16.3M | −$22.1M | −$43.5M | −$55.3M | −$62.7M | −$93.4M | −$28.9M |
| Net margin | -484.6% | — | — | -15267.7% | -4055.6% | -4023.1% | -6090.9% | -7266.1% |
| EPS (diluted) | -0.98 | -62.50 | -2.59 | -3.35 | -1.83 | -1.26 | -1.43 | -18.62 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3M | $-0.99 | $-0.99–$-0.99 | 1 |
| 2027 | $6M | $-7.07 | $-7.07–$-7.07 | 1 |
| 2028 | $37M | $-4.01 | $-4.01–$-4.01 | 1 |
| 2029 | $64M | $-1.33 | $-1.33–$-1.33 | 1 |
Forward consensus · source: Financial Modeling Prep
LYRA THERAPEUTICS INC
No one on the platform currently holds LYRA.
No tracked institution reports a position in LYRA as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-05-28 | 1-for-50reverse |
No one on the platform has traded LYRA yet.
| $4M |
| — |
| CINGCingulate Inc. | $4.96 | +4.20% | $28M | — |
| CLRBCellectar Biosciences, Inc. | $2.52 | +2.02% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$LYRA Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC https://investors.lyratherapeutics.com/news-releases/news-release-details/lyra-therapeutics-inc-announces-intention-voluntarily-file-form It is already trading OTC, so the Form 25 filing is a formality. However, after the Form 25 is effective, they intend to file a Form 15. This will terminate its registration with the SEC. The company will no longer be subject to SEC reporting requirements after the Form 15 filing. They won't be required to make any more 10-K, 10-Q, or 8-K filings after the Form 15 is effective.
View on StockTwits ↗$LYRA agreed to terminate part of its Watertown lease early, forfeiting its security deposit and paying $1.X million to exit the space sooner.
View on StockTwits ↗$LYRA Maria still holds 1.1M shares and Jason 519K…clearly they don’t view their stakes as worthless...at this point just acquire it for $10 a share and put an end to the chicanery..and don’t take this as investment advice..this could absolutely go to zero, so any position should be treated accordingly...that said, I find it difficult to believe the enterprise is truly worthless🤷♂️
View on StockTwits ↗$LYRA anyone still holding? Holding 563 shares @ .3501 still… can’t hurt
View on StockTwits ↗$LYRA I sold this off at $30 last June. What the fuck happened to it???
View on StockTwits ↗$LYRA Begins trading on pink sheets today https://www.otcmarkets.com/stock/LYRA/overview
View on StockTwits ↗$LYRA got the delisting/non-compliance filing on record...
View on StockTwits ↗$LYRA 17:11 on Mar. 16 2026 Lyra Therapeutics Withdraws Appeal Of Nasdaq Delisting Determination; Trading In Co's Common Stock To Be Suspended At Open On March 17, 2026 #tradeideas
View on StockTwits ↗$LYRA very unfortunate but I bought it 30+cents for lottery play even it goes to zero few hundred dollars is mean nothing to me good luck all
View on StockTwits ↗$LYRA FINRA confirms it will begin trading OTC tomorrow. Same symbol. https://otce.finra.org/otce/dailyList?viewType=Additions
View on StockTwits ↗$LYRA Delisted. Will be suspended from trading on NASDAQ at the open on March 17. https://www.sec.gov/ix?doc=/Archives/edgar/data/1327273/000119312526108439/d55950d8k.htm "On March 13, 2026, Lyra Therapeutics, Inc. (the “Company”) received a letter (the “Letter”) from the Nasdaq Hearings Advisor at The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has withdrawn its appeal of the delisting determination issued by Nasdaq’s Listings Qualifications Staff on February 2, 2026. The Letter further confirms that as a result of the withdrawal of the Company’s appeal, trading in the Company’s common stock will be suspended at the open of trading on Tuesday, March 17, 2026."
View on StockTwits ↗$LYRA De-listinf or bankruptcy? dont see any news
View on StockTwits ↗$LYRA Will be liquidation only on webull and robhinhood tomorrow learn from what happened to $BHAT
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 24.9× sales vs its 4981.8× historical median P/S.
Fair value ≈ $119.39 · price $0.60 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.